bioMérieux - 2010 Business Review

19 January, 2011

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for fourth-quarter and full-year 2010.

At constant exchange rates and scope of consolidation:

  • Sales growth: 4.9%
  • Excluding the H1N1 impact, sales growth: 6.4% vs. 6.2% in 2009
  • Rapid rise in “Emerging 7” sales: + 27%, excluding the H1N1 impact
  • Strong growth drivers
    • Clinical microbiology: + 7.6%
    • VIDAS®: + 9.2%
    • Industrial applications: + 8.1%
  • Robust instrument sales: + 19.5%

Download the Complete Press Release:

Pioneering Diagnostics